Sony DADC to Enter Into a Manufacturing Agreement with Trinean
News Apr 04, 2014
Trinean has announced that it has entered into a manufacturing and supply agreement with Sony DADC for the production of microfluidic disposables fit for storage and micro-cuvette analysis of droplet-sized biological samples.
Sony DADC BioSciences, the leading OEM supplier of smart polymer-based consumables, is using their ISO 13485 facility in Salzburg, Austria to manufacture to Trinean’s specifications.
“We are very pleased to start working with Sony DADC,” comments Philippe Stas, CEO of Trinean. "The Sony DADC team has an in-depth understanding of microfluidic disposable production and optimization. High optical quality and reproducibility in the production process are crucial for an accurate analysis of DNA, RNA and protein samples”.
Trinean’s spectrophotometers redefine manual UV/VIS bio-sample quantification into a convenient, high speed solution. The DropSense96™ reader is geared to high throughput and integrated sample QC analysis. The Xpose™ ‘Touch & Go’ approach avoids time-consuming sample loading and cleaning steps thereby minimizing the hands-on time on the reader.
Both platforms include proprietary Spectral Content Profiling software for dye-free quantitation of DNA, RNA or protein yields combined with the detection of contaminating levels of residuals for content QC.
“We are delighted to have gained the trust of the Trinean team. Based on our extensive experience in translating polymer science into robust manufacturing processes, we look forward to supplying the microfluidic disposables to Trinean as they grow their global business footprint,” said Dr. Chris Mauracher, Senior Vice President of the BioSciences division of Sony DADC.
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
10th Edition of International Conference on Structural Biology 2018
Mar 15 - Mar 17, 2018